NYSE:RVTYLife Sciences
Reassessing Revvity (RVTY) Valuation After Strong Q4 Results And Weaker Guidance Versus Peers
Governance shifts and fresh shareholder pressure
Revvity (RVTY) is drawing fresh attention after solid Q4 numbers and revenue guidance were followed by a weaker peer comparison, a sharp swing in sentiment, and new governance efforts from both the board and an activist investor.
See our latest analysis for Revvity.
At a share price of $85.94, Revvity is trading well below its recent highs, with a 30 day share price return of a 14.34% decline and a 1 year total shareholder return of a 19.67%...